These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33953680)
1. Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases. Rolandsson Enes S; Krasnodembskaya AD; English K; Dos Santos CC; Weiss DJ Front Pharmacol; 2021; 12():647652. PubMed ID: 33953680 [TBL] [Abstract][Full Text] [Related]
8. Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury. Horie S; Gonzalez H; Brady J; Devaney J; Scully M; O'Toole D; Laffey JG Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884645 [TBL] [Abstract][Full Text] [Related]
9. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease. Calcat-I-Cervera S; Sanz-Nogués C; O'Brien T Front Med (Lausanne); 2021; 8():728496. PubMed ID: 34616756 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges. Cao C; Zhang L; Liu F; Shen J J Inflamm Res; 2022; 15():5235-5246. PubMed ID: 36120184 [TBL] [Abstract][Full Text] [Related]
16. Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury. Florian M; Wang JP; Deng Y; Souza-Moreira L; Stewart DJ; Mei SHJ Stem Cell Res Ther; 2021 Mar; 12(1):184. PubMed ID: 33726829 [TBL] [Abstract][Full Text] [Related]
17. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS. Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L Front Immunol; 2021; 12():738697. PubMed ID: 34659231 [TBL] [Abstract][Full Text] [Related]
18. Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome. Han J; Li Y; Li Y Stem Cells Int; 2019; 2019():5432134. PubMed ID: 31885615 [TBL] [Abstract][Full Text] [Related]
19. Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases. Lopes-Pacheco M; Rocco PRM Front Pharmacol; 2023; 14():1067422. PubMed ID: 37007034 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis. Fengyun W; LiXin Z; Xinhua Q; Bin F Cell Transplant; 2020; 29():963689720969186. PubMed ID: 33164559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]